Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon

Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT™ Drug-Coated Balloon (DCB).